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Background: Renal sympathetic denervation is a promising technique for the treatment of resistant hypertension. We evaluated a novel method for 
chemical sympathetic denervation of the renal artery by local delivery of vincristine, an antineoplastic drug with potential for peripheral neurotoxicity, 
using a dedicated catheter in an animal model.
Methods: Local delivery of vincristine by a specially designed catheter, was performed unilaterally in the renal arteries of 14 juvenile Landrace 
swine. The procedure was repeated in the contralateral renal artery with a placebo mixture. Animals were euthanized at 28 days and histological 
specimens of renal arteries and perirenal arterial stroma containing renal nerves were extracted and sectioned. The number of uninjured nerves in 
each histological section was then quantified.
Results: In all animals delivery of vincristine and placebo mixtures was successful and uncomplicated. Both vincristine- and placebo-treated renal 
arteries were angiographically patent at the end of the procedure. The mean number of intact nerves in all sections was significantly lower in the 
group of vincristine (p<0.05). Figure presents sections with immunostaining for neuron-specific enolase in (A) vincristine- and (B) placebo-treated 
arteries.
Conclusions: Catheter-based delivery of vincrinstine in the renal artery of swine is feasible and results in significant reduction in the number of 
renal nerves. Our findings warrant further confirmation in animal and human studies.
 
